Skip to main content
. 2017 May 17;8(39):65265–65280. doi: 10.18632/oncotarget.17941

Figure 5. The survival analysis of esophageal cancer patients for the expressions of Twist1 and various CAF markers in cancer stromal fibroblasts.

Figure 5

Overall and disease free survival rates revealed by Kaplan-Meier survival analysis are lower in ESCC patients whose stromal fibroblasts are positive for both Twist1 and PDGFRα (A, E), Twist1 and SMA (B, F), Twist1 and Tenascin C (C, G), and Twist1 and FSP1 (D, H) than other patients.